Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.45
-0.05 (-0.53%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Avid Bioservices Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Avid Bioservices stock have an average target of 12.5, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 32.28% from the current stock price of 9.45.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CDMO stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | -15.34% | Jul 3, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | -15.34% | Apr 30, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +26.98% | Mar 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | -25.93% | Mar 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $15 → $7 | Buy | Maintains | $15 → $7 | -25.93% | Dec 8, 2023 |
Financial Forecast
Revenue This Year
167.28M
from 139.91M
Increased by 19.56%
Revenue Next Year
205.13M
from 167.28M
Increased by 22.63%
EPS This Year
-0.19
from -2.23
EPS Next Year
n/a
from -0.19
Revenue Forecast
| Revenue | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|
| High | 183.8M | 231.0M | 555.2M | 721.8M |
| Avg | 167.3M | 205.1M | 539.3M | 701.1M |
| Low | 150.1M | 183.7M | 518.2M | 673.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2028 | 2029 |
|---|---|---|---|---|
| High | 31.3% | 38.1% | 170.7% | 33.8% |
| Avg | 19.6% | 22.6% | 162.9% | 30.0% |
| Low | 7.3% | 9.8% | 152.6% | 24.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.17 | 0.11 |
| Avg | -0.19 | - |
| Low | -0.22 | -0.12 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.